| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |